Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8466904 | Cytotherapy | 2018 | 18 Pages |
Abstract
The prevalence and biological potential of CTPs are different between patients and tissue sources and lack variation in classical MSC markers. Other markers are more likely to discriminate differences between cell populations in biological performance. Understanding the underlying reasons for variation in the concentration, prevalence, marker expression and biological potential of CTPs between patients and source tissues and determining the means of managing this variation will contribute to the rational development of cell-based clinical diagnostics and targeted cell-based therapies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Maha A. Qadan, Nicolas S. Piuzzi, Cynthia Boehm, Wesley Bova, Malcolm Jr., Ronald J. Midura, Vincent C. Hascall, Christopher Malcuit, George F. Muschler,